Loading clinical trials...
Loading clinical trials...
The purpose of this study is to examine the feasibility, acceptability, and preliminary efficacy of a digital intervention for co-occurring cannabis use and depression. Participants will be randomized...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Massachusetts General Hospital
Collaborators
NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more
NCT07466875 · Nicotine Dependence, Nicotine Withdrawal, and more
NCT05855668 · Alcohol Use Disorder, Cannabis Use Disorder
NCT06690151 · Heart Disease Congenital, Neurodevelopmental Disorder
NCT01778504 · Neuropsychiatric Disorder, Neurological Disorder, and more
Massachusetts General Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions